格隆汇1月22日丨多瑞医药(301075.SZ)公布，为提高公司资产管理效率，优化投资结构，降低管理成 本，西藏多瑞医药股份有限公司于近期注销了全资子公司西藏晨韵实业有限公司（简称"西藏晨韵"）。 ...

Core Viewpoint - The company, Xiugang Co., Ltd. (300160.SZ), has announced the disposal of several subsidiaries to optimize resource allocation and internal management structure, aiming to reduce management costs [1] Group 1: Subsidiaries Involved - The subsidiaries being disposed of include Jiangsu Xiugang Optoelectronic Glass Technology Co., Ltd. (referred to as "Xiugang Optoelectronic"), Jiangsu Xiugang New Materials Research Institute Co., Ltd. (referred to as "Xiugang Research Institute"), and Xiugang Glass International Limited (Mexico) (referred to as "Mexico Xiugang") [1] Group 2: Strategic Intent - The decision is based on the company's development plan and the actual operational conditions of the subsidiaries, indicating a strategic move to streamline operations and enhance efficiency [1]

Core Viewpoint - The company, 泰尔重工股份有限公司, has decided to dissolve its subsidiary, 马鞍山泰尔智能产业园发展有限公司, due to a lack of substantial business activities and to streamline operations and reduce management costs [5][8]. Group 1: Board Meeting and Decisions - The seventh board meeting was held on December 2, 2025, with all nine directors present, and the decision to dissolve the subsidiary was unanimously approved with eight votes in favor [2][3]. - The decision to dissolve the subsidiary does not require shareholder approval as it is classified as a related party transaction and not a major asset restructuring [6][8]. Group 2: Subsidiary Details - The subsidiary, 马鞍山泰尔智能产业园发展有限公司, was established on November 5, 2015, with a registered capital of 30 million RMB and was involved in various activities including smart factory development and real estate management [7]. - The subsidiary has not engaged in substantial business activities during its existence, prompting the decision for dissolution to enhance operational efficiency [7][8]. Group 3: Impact on the Company - The dissolution of the subsidiary is expected to have no adverse effects on the company's financial or operational status, aligning with the company's strategic goals and improving management efficiency [8]. - The company has confirmed that there are no other related party transactions with the associated party, 上海曦泰投资有限公司, aside from the dissolution [9]. Group 4: Independent Directors' Opinion - The independent directors reviewed the proposal and concluded that the dissolution of the subsidiary would not harm the interests of the company or its shareholders, particularly minority shareholders [11].

Core Viewpoint - The company has announced the decision to deregister its subsidiary, Chongqing Gongyue Supply Chain Co., Ltd., to reduce management costs and optimize resource allocation [1] Group 1 - Chongqing Gongyue is a controlling subsidiary of Ningbo Xiyue Zhixing Technology Co., Ltd. [1] - The decision to deregister was made in agreement with other shareholders of Chongqing Gongyue [1]

Core Viewpoint - The company has completed the deregistration of its wholly-owned subsidiary, Xiamen Keda Li Precision Industry Co., Ltd., to optimize resource allocation and reduce management costs, thereby enhancing overall competitiveness and supporting long-term development goals [1][2]. Group 1 - The decision to deregister Xiamen Keda Li was approved during the fifth board meeting held on April 16, 2025 [1]. - The business operations of Xiamen Keda Li will be integrated into another wholly-owned subsidiary, Fujian Keda Li Precision Industry Co., Ltd. [1][2]. - The company emphasizes that this action will not harm the interests of the company or its shareholders [2].

Group 1 - The core point of the article is that Postal Savings Bank of China (PSBC) is merging with its wholly-owned subsidiary, Postal Bank of China, to optimize management and business structure [1] Group 2 - The merger aims to achieve strategic integration by incorporating the online operational experience of Postal Bank of China into PSBC, enhancing its online business capabilities [1] - The merger will optimize resource allocation, as the business resources and talent from Postal Bank of China will inject new momentum into PSBC's development [1] - The merger is expected to reduce management costs, allowing PSBC to allocate resources to more complementary areas and improve overall operational efficiency [1]

Core Viewpoint - The company has decided to optimize resource allocation and reduce management costs by proposing the cancellation of its subsidiary, Step Long (Guangzhou) Medical Diagnostic Technology Co., Ltd. [1] Group 1 - The fifth session of the company's board of directors held on September 4, 2025, approved the proposal to cancel Step Long (Guangzhou) Medical Diagnostic Technology Co., Ltd. [1] - The decision is part of a broader strategy to enhance operational efficiency within the company [1]

Overview - Beijing Chunz中 Technology Co., Ltd. plans to absorb and merge its wholly-owned subsidiary, Beijing Shijie Hengtong Technology Co., Ltd. [1][2] - The merger has been approved by the company's board of directors and does not constitute a major asset restructuring as per relevant regulations [1][2] - The merger will not have a substantial impact on the company's financial status or operating results, nor will it harm the interests of the company and its shareholders [1][5] Merger Details - The purpose of the merger is to integrate resources, improve asset operation efficiency, optimize organizational structure, and reduce management costs [5] - After the merger, Shijie Hengtong's independent legal status will be canceled, and all its assets, debts, and business will be inherited by the company [1][5] - The merger will not involve changes to the company's registered capital or require shareholder approval [2] Subsidiary Information - Beijing Shijie Hengtong Technology Co., Ltd. was established on July 19, 2013, with a registered capital of 5 million RMB [2] - The company is wholly owned by Beijing Chunz中 Technology Co., Ltd. [2] Financial Data - As of March 31, 2025, Shijie Hengtong's total assets were approximately 33.25 million RMB, and net assets were approximately 32.42 million RMB [4] - For the year 2024, Shijie Hengtong reported total revenue of approximately 19.64 million RMB and a net profit of approximately 8.13 million RMB [4]